Niagen Bioscience

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NAGE and other ETFs, options, and stocks.

About NAGE

Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). 

CEO
Robert N. Fried
CEORobert N. Fried
Employees
117
Employees117
Headquarters
Los Angeles, California
HeadquartersLos Angeles, California
Founded
1999
Founded1999
Employees
117
Employees117

NAGE Key Statistics

Market cap
221.16M
Market cap221.16M
Price-Earnings ratio
14.82
Price-Earnings ratio14.82
Dividend yield
—
Dividend yield—
Average volume
617.12K
Average volume617.12K
High today
$2.80
High today$2.80
Low today
$2.62
Low today$2.62
Open price
$2.72
Open price$2.72
Volume
1.57M
Volume1.57M
52 Week high
$7.95
52 Week high$7.95
52 Week low
$2.61
52 Week low$2.61

Stock Snapshot

With a market cap of 221.16M, Niagen Bioscience(NAGE) trades at $2.76. The stock has a price-to-earnings ratio of 14.82.

During the trading session on 2026-10-03, Niagen Bioscience(NAGE) shares reached a daily high of $2.80 and a low of $2.62. At a current price of $2.76, the stock is +5.5% higher than the low and still -1.4% under the high.

Trading volume for Niagen Bioscience(NAGE) stock has reached 1.57M, versus its average volume of 617.12K.

The stock's 52-week range extends from a low of $2.61 to a high of $7.95.

The stock's 52-week range extends from a low of $2.61 to a high of $7.95.

NAGE News

TipRanks 2d
Niagen Bioscience launches ‘Don’t Get Old. Age Better.’ campaign

Niagen Bioscience (NAGE), announced the launch of “Don’t Get Old. Age Better.,” a new brand campaign for its Niagen brand and sub-brands Tru Niagen and Niagen P...

Nasdaq 2d
Niagen Bioscience Puts 25 Years of NAD+ Science Behind "Don't Get Old. Age Better.®" a New Campaign for its Niagen® Brand Featuring Legendary Surfer Kelly Slater - Nasdaq

...

Niagen Bioscience Puts 25 Years of NAD+ Science Behind "Don't Get Old. Age Better.®" a New Campaign for its Niagen® Brand Featuring Legendary Surfer Kelly Slater - Nasdaq
TipRanks 3d
Niagen Bioscience enters start-up agreement with Mass General Brigham

Niagen Bioscience (NAGE) announced a Start-Up Agreement with Mass General Brigham to begin detailed planning for what is envisioned to be the largest and most c...

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own NAGE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.